List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 6 studies with search of:   "Proteolix" [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: carfilzomib
2 Recruiting Study of the Safety and Pharmacokinetics of Carfilzomib in Subjects With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function
Conditions: Multiple Myeloma;   Renal Insufficiency
Intervention: Drug: Carfilzomib for Injection, PR-171
3 Recruiting Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: carfilzomib
4 Recruiting Phase 1b Multicenter Study of Carfilzomib With Lenalidomide and Dexamethasone in Relapsed Multiple Myeloma
Condition: Relapsed Multiple Myeloma
Intervention: Drug: Carfilzomib with Lenalidomide and Dexamethasone
5 Recruiting Safety Study of the Proteasome Inhibitor PR-171 (Carfilzomib for Injection) in Patients With Hematological Malignancies
Conditions: Multiple Myeloma;   Non-Hodgkin's Lymphoma;   Waldenstrom's Macroglobulinemia
Intervention: Drug: PR-171 for injection (carfilzomib)
6 Recruiting Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors
Conditions: Ovarian Cancer;   Renal Cancer;   Non-Small Cell Lung Cancer;   Small-Cell Lung Cancer;   Solid Tumors
Intervention: Drug: carfilzomib

  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services